| Biologic Therapy |
1 |
1 |
| Cornea and External Disease |
0 |
0.7 |
| Conjunctivitis |
0 |
0.8 |
| Dermatitis |
0 |
0.98 |
| Orbit |
0 |
0.33 |
| Skin and Soft Tissue Infection |
0 |
0.26 |
| Keratitis |
0 |
0.25 |
| Keratoconjunctivitis |
0 |
0.25 |
| Otolaryngology |
0 |
0.24 |
| Upper Respiratory Tract Infection |
0 |
0.24 |
| Clinical Research |
0 |
0.17 |
| Healthcare and Medical Technology |
0 |
0.17 |
| Oregon |
0 |
0.17 |
| Respiratory Tract |
0 |
0.17 |
| Atopic Dermatitis |
0 |
0.99 |
| Topical Corticosteroid |
0 |
0.12 |
| Patient Safety |
0 |
0.09 |
| Adverse Effects |
0 |
0.08 |
| Board Certification |
0 |
0.08 |
| Chronic Disease |
0 |
0.08 |
| Corticosteroids |
0 |
0.08 |
| Cytokines |
0 |
0.08 |
| Eczema |
0 |
0.08 |
| Fellowship |
0 |
0.08 |
| Grant |
0 |
0.08 |
| Interleukin |
0 |
0.08 |
| Pruritus |
0 |
0.08 |